Live Breaking News & Updates on Venn Life Sciences|Page 3

Stay updated with breaking news from Venn life sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

hVIVO plc £6.3m HRV Contract Signed with Biotechnology Client

HVIVO plc £6.3m HRV Contract Signed with Biotechnology Client ....

Andrew Catchpole , Yamin Mo Khan , Venn Life Sciences , Canary Wharf , Human Challenge Study , Mo Khan , Chief Executive Officer , Challenge Model , Chief Scientific Officer , Open Orphan ,

hVIVO bolstered by strong industry tailwinds, says US investment bank

Stifel, the American investment bank, has initiated coverage of hVIVO PLC, the contract research organisation (CRO) specialising in human challenge clinical. ....

United States , Venn Life Sciences ,

hVIVO plc report positive results from influenza human challenge study

HVIVO plc report positive results from influenza human challenge study ....

City Of , United Kingdom , Tower Hamlets , Andrew Catchpole , Venn Life Sciences , Chronic Obstructive Pulmonary Disease , Chief Scientific Officer , Open Orphan ,

HVIVO : Interim Results 2023 -Today at 05:10 am

12 September 2023

hVIVO plc

Interim results

Strong first half performance and record forward. ....

United Kingdom , Tower Hamlets , United States , City Of , Geoff Nash , Anthony Farrell , Yamin Mo Khan , Ben Cryer , Stephanie Cuthbert Phillip , Phil Walker , Nigel Birks , Edward Mansfield , Louis Ashe Jepson , Stephen Pinkerton , Niall Gilchrist , Venn Life Sciences , Cavendish Capital Markets Ltd Joint Broker , Investor Meet Company , Regulatory Authority , Full Year Revenue , North American , Fast Track , Mo Khan , Chief Executive Officer , Chief Financial Officer , Nominated Adviser ,

Pharma services company Hvivo delivers record revenues in first half

Company, formerly known as Open Orphan, described the first half of 2023 as ‘another period of excellent growth’ ....

City Of , United Kingdom , Cathal Friel , Venn Life Sciences , Open Orphan , Life Sciences ,